Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc. Approximately 20–30% of human lung adenocarcinomas (LUADs) harbor mutations in Kelch-like ECH-associated protein 1 (KEAP1) that hyperactivate the nuclear factor, erythroid 2-like 2 (NFE2L2) antioxidant program. We previo...
Main Authors: | Romero, Rodrigo, Sánchez-Rivera, Francisco J, Westcott, Peter MK, Mercer, Kim L, Bhutkar, Arjun, Muir, Alexander, González Robles, Tania J, Lamboy Rodríguez, Swanny, Liao, Laura Z, Ng, Sheng Rong, Li, Leanne, Colón, Caterina I, Naranjo, Santiago, Beytagh, Mary Clare, Lewis, Caroline A, Hsu, Peggy P, Bronson, Roderick T, Vander Heiden, Matthew G, Jacks, Tyler |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2021
|
Online Access: | https://hdl.handle.net/1721.1/133110 |
Similar Items
-
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
by: Sayin, Volkan I., et al.
Published: (2018) -
YAP and TAZ have Functionally Redundant Roles in Uveal Melanoma
by: Lamboy Rodríguez, Swanny A.
Published: (2024) -
Identification of genotype-specific dependencies in Keap1-deficient lung adenocarcinoma
by: Romero, Rodrigo,Ph. D.Massachusetts Institute of Technology.
Published: (2019) -
KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer
by: Krall, Elsa B, et al.
Published: (2017) -
A GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cells
by: Patel, Rupesh S, et al.
Published: (2022)